Biomedical Engineering Reference
In-Depth Information
13. Zhang L, Eisenberg A (1995) Multiple morphologies of crew-cut aggregates of polystyrene-
b
-poly(acrylic acid) block copolymers. Science 1268:1728-1731
14. Dou H, Jiang M, Peng H et al (2003) pH-dependent self-assembly: micellization and micelle-
hollow-sphere transition of cellulose-based copolymers. Angew Chem Int Ed 42:1516-1519
15. Reihs T, Muller M, Lunkwitz K (2004) Preparation and adsorption of refined polyelectrolyte
complex nanoparticles. J Colloid Interface Sci 271:69-79
16. Kang N, Perron ME, Prudhomme RE et al (2005) Stereocomplex block copolymer micelles:
core-shell nanostructures with enhanced stability. Nano Lett 5:315-319
17. Panyam J, Labhasetwar V (2003) Biodegradable nanoparticles for drug and gene delivery to
cells and tissue. Adv Drug Deliv Rev 55:329-347
18. Torchilin VP (2006) Multifunctional nanocarriers. Adv Drug Deliv Rev 58:1532-1555
19. Vasir JK, Labhasetwar V (2007) Biodegradable nanoparticles for cytosolic delivery of
therapeutics. Adv Drug Deliv Rev 59:718-728
20. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature
392:245-252
21. Gamvrellis A, Leong D, Hanley JC et al (2004) Vaccines that facilitate antigen entry into
dendritic cells. Immunol Cell Biol 82:506-516
22. Harding CV, Song R (1994) Phagocytic processing of exogenous particulate antigens by
macrophages for presentation by class I MHC molecules. J Immunol 153:4925-4933
23. Wang X, Akagi T, Akashi M et al (2007) Development of core-corona type polymeric
nanoparticles as an anti-HIV-1 vaccine. Mini-Rev Org Chem 4:281-290
24. Foged C, Brodin B, Frokjaer S et al (2005) Particle size and surface charge affect particle
uptake by human dendritic cells in an in vitro model. Int J Pharm 298:315-322
25. Kanchan V, Panda AK (2007) Interactions of antigen-loaded polylactide particles with
macrophages and their correlation with the immune response. Biomaterials 28:5344-5357
26. O'Hagan DT, Jeffery H, Davis SS (1994) The preparation and characterization ofpoly
(lactide-co-glycolide) microparticles: III. Microparticle/polymer degradation rates and the
in vitro release of a model protein. Int J Pharm 103:37-45
27. Li X, Deng X, Yuan M et al (2000) In vitro degradation and release profiles of poly-
DL-lactide-poly(ethylene glycol) microspheres with entrapped proteins. J Appl Polym Sci
78:140-148
28. Liggins RT, Burt HM (2001) Paclitaxel loaded poly(L-lactic acid) microspheres: properties
of microspheres made with low molecular weight polymers. Int J Pharm 222:19-33
29. Lemoine D, Francois C, Kedzierewicz F et al (1996) Stability study of nanoparticles of poly
(
e
-caprolactone), poly(D, L-lactide) and poly(D, L-lactide-co-glycolide). Biomaterials
17:2191-2197
30. Jiang W, Gupta RK, Deshpande MC et al (2005) Biodegradable poly(lactic-co-glycolic acid)
microparticles for injectable delivery of vaccine antigens. Adv Drug Deliv Rev 57:391-410
31. Mohamed F, van der Walle CF (2008) Engineering biodegradable polyester particles with
specific drug targeting and drug release properties. J Pharm Sci 97:71-87
32. Kumari A, Yadav SK, Yadav SC (2009) Biodegradable polymeric nanoparticles based drug
delivery systems. Colloids Surf B 75:1-18
33. O'Donnell PB, McGinity JW (1997) Preparation of microspheres by the solvent evaporation
technique. Adv Drug Deliv Rev 28:25-42
34. Lu JM, Wang X, Marin-Muller C et al (2009) Current advances in research and clinical
applications of PLGA-based nanotechnology. Expert Rev Mol Diagn 9:325-341
35. Gaucher G, Dufresne MH, Sant VP et al (2005) Block copolymer micelles: preparation,
characterization and application in drug delivery. J Control Release 109:169-188
36. Letchford K, Burt H (2007) A review of the formation and classification of amphiphilic block
copolymer
nanoparticulate
structures: micelles,
nanospheres,
nanocapsules
and
polymersomes. Eur J Pharm Biopharm 65:259-269
37. Holowka EP, Pochan DJ, Deming TJ (2005) Charged polypeptide vesicles with controllable
diameter. J Am Chem Soc 127:12423-12428
